PNT
POINT Biopharma Global Inc. Common Stock
Delisted
PNT was delisted on the 26th of December, 2023.
105 hedge funds and large institutions have $470M invested in POINT Biopharma Global Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 40 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
105
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$34.9M | |
| 2 | +$21.8M | |
| 3 | +$17.2M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$13.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$10.6M |
Top Sellers
| 1 | -$61.3M | |
| 2 | -$5.28M | |
| 3 | -$4.44M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.6M |
| 5 |
RI
RTW Investments
New York
|
-$3.34M |